Refine
Has Fulltext
- yes (12)
Is part of the Bibliography
- yes (12) (remove)
Year of publication
Document Type
- Journal article (11)
- Doctoral Thesis (1)
Keywords
- T cells (3)
- phosphoantigen (3)
- BTN3 (2)
- alpaca (2)
- butyrophilin (2)
- butyrophilin 3 (2)
- cell staining (2)
- evolution (2)
- γδ T cell (2)
- ABCG2 (1)
- ATP-Abhängigkeit (1)
- ATP-dependent (1)
- BTN (1)
- BTN2 (1)
- BTN2A1 (1)
- BTN3A1 (1)
- Cell cycle (1)
- DETC (1)
- Dendritische Zelle (1)
- Krebs <Medizin> (1)
- Maus (1)
- NRF2 (1)
- Origin of Recognition (1)
- Replikation (1)
- Replikationsursprung (1)
- Skint1 (1)
- T cell receptor (1)
- TRDV2 (1)
- TRGV9 (1)
- Vγ9Vδ2 (1)
- Vγ9Vδ2 T cell (1)
- Zellzyklus (1)
- antigen presentation (1)
- binding analysis (1)
- butyrophilin 2A1 (1)
- butyrophilins (1)
- co-evolution (1)
- coevolution (1)
- cytotoxic T cells (1)
- fluorescence-activated cell sorting (1)
- gammadelta T cells (1)
- glycolipids (1)
- human (1)
- immune therapy (1)
- immunosurveillance (1)
- interleukins (1)
- lipids (1)
- lymph nodes (1)
- lymphomas (1)
- major histocompatibility complex (1)
- mevalonate pathway (1)
- mouse models (1)
- murine (1)
- nine-banded armadillo (1)
- oligomers (1)
- phosphoantigens (1)
- placental mammals (1)
- preRC (1)
- präRC (1)
- surfactants (1)
- tumor (1)
- γδ T cells (1)
- γδ TCR (1)
Background: Dendritic cells (DC) can act tolerogenic at a semi-mature stage by induction of protective CD4+ T cell and NKT cell responses. Methodology/Principal Findings: Here we studied the role of the co-inhibitory molecule B7-H1 (PD-L1, CD274) on semimature DC that were generated from bone marrow (BM) cells of B7-H12/2 mice and applied to the model of Experimental Autoimmune Encephalomyelitis (EAE). Injections of B7-H1-deficient DC showed increased EAE protection as compared to wild type (WT)-DC. Injections of B7-H12/2 TNF-DC induced higher release of peptide-specific IL-10 and IL-13 after restimulation in vitro together with elevated serum cytokines IL-4 and IL-13 produced by NKT cells, and reduced IL-17 and IFN-c production in the CNS. Experiments in CD1d2/2 and Ja2812/2 mice as well as with type I and II NKT cell lines indicated that only type II NKT cells but not type I NKT cells (invariant NKT cells) could be stimulated by an endogenous CD1d-ligand on DC and were responsible for the increased serum cytokine production in the absence of B7-H1. Conclusions/Significance: Together, our data indicate that BM-DC express an endogenous CD1d ligand and B7-H1 to ihibit type II but not type I NKT cells. In the absence of B7-H1 on these DC their tolerogenic potential to stimulate tolerogenic CD4+ and NKT cell responses is enhanced.
Peripheral T cell lymphomas (PTCLs) are associated with a poor prognosis due to often advanced disease at the time of diagnosis and due to a lack of efficient therapeutic options. Therefore, appropriate animal models of PTCL are vital to improve clinical management of this disease. Here, we describe a monoclonal CD8\(^+\) CD4\(^−\) αβ T cell receptor Vβ2\(^+\) CD28\(^+\) T cell lymphoma line, termed T8-28. T8-28 cells were isolated from an un-manipulated adult BALB/c mouse housed under standard pathogen-free conditions. T8-28 cells induced terminal malignancy upon adoptive transfer into syngeneic BALB/c mice. Despite intracellular expression of the cytotoxic T cell differentiation marker granzyme B, T8-28 cells appeared to be defective with respect to cytotoxic activity as read-out in vitro. Among the protocols tested, only addition of interleukin 2 in vitro could partially compensate for the in vivo micro-milieu in promoting growth of the T8-28 lymphoma cells.